Stathmin expression in metastatic colorectal cancer.

Premila Devi LeiphrakpamAudrey J LazenbyLynette M SmithMichael G BrattainChandrakanth Are

Published in: Journal of surgical oncology (2021)

Stathmin expression correlated with worse patient prognosis in mCRC patients and positively correlated with increased cell proliferation. Together, our findings indicate stathmin as a novel potential marker for increased risk of CRC-specific mortality and identify stathmin as an attractive therapeutic target for the treatment of mCRC.

Keyphrases

poor prognosis
metastatic colorectal cancer
cell proliferation
end stage renal disease
ejection fraction
newly diagnosed
binding protein
case report
peritoneal dialysis
long non coding rna
risk factors
cell cycle
risk assessment
signaling pathway
pi k akt
patient reported